CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target
Leukemia · 2026-06 · 40 (6) · 1163-1175
DOI: 10.1038/s41375-026-02899-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, online erschienen am 23.03.2026. Verfasst von Stefan Forster und 19 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Multiple Myeloma, CD27 Ligand, Signal Transduction, Tumor Necrosis Factor Receptor Superfamily, Member 7. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation).
Abstract (Originalsprache)
The increasing therapeutic options for multiple myeloma (MM) have significantly improved long-term survival for many patients. However, disease progression remains inevitable due to the emergence of drug-resistant myeloma cell populations, often culminating in extramedullary disease manifestations. In this study, we identified CD70-expressing myeloma cells as critical drivers of disease progression and propagation. CD70 expression in MM cells is an independent negative prognostic factor for overall survival. Mechanistically, CD70/CD27 signaling activates the MAPK/ERK and Wnt signaling pathways in MM cell lines and primary patient-derived MM samples, promoting increased cell cycling and proliferation. This proliferative advantage results in elevated CD70 expression in advanced MM stages, particularly in extramedullary myeloma. Functional inhibition of CD70/CD27 signaling, achieved either by generating CD70-knockout primary MM cells or with blocking monoclonal antibodies, completely abrogated tumor growth in xenotransplantation models. Furthermore, the ADCC-enhanced anti-CD70 antibody, cusatuzumab, demonstrated high efficacy in treating myeloma in xenotransplantation models. Collectively, these findings underscore the critical role of CD70/CD27 signaling in activating MAPK/ERK and Wnt pathways essential for MM progression. Targeting CD70 with blocking or ADCC-enhanced antibodies represents a promising therapeutic strategy, particularly for advanced MM stages characterized by high CD70 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
- Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Institute of Pathology, Technical University Munich, Munich, Germany.
- Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
- Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
- Department of Laboratory Medicine and Pathology, Ohiohealth, Columbus, OH, USA.
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
Zitieren
APA
Forster, S., Reinhardt, C., Boy, M., Wegmüller, A., Hinrichsen, A., Schürch, C. M., Brühl, F. K., Fend, F., Tzankov, A., Kronig, M. N., Römmele, M., Glück, A., Lüscher, B., Legros, M., Bacher, U., Seipel, K., Pabst, T., Radpour, R., Riether, C., & Ochsenbein, A. F. (2026). CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target. Leukemia, 40(6), 1163-1175. https://doi.org/10.1038/s41375-026-02899-1
Vancouver
Forster S, Reinhardt C, Boy M, Wegmüller A, Hinrichsen A, Schürch CM, et al. CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target. Leukemia. 2026;40(6):1163-1175. doi:10.1038/s41375-026-02899-1
BibTeX
@article{Forster2026,
author = {Forster, Stefan and Reinhardt, Chantal and Boy, Maxime and Wegmüller, Adrian and Hinrichsen, Alessio and Schürch, Christian M and Brühl, Frido K and Fend, Falko and Tzankov, Alexandar and Kronig, Marie-Noëlle and Römmele, Michaela and Glück, Angéline and Lüscher, Benjamin and Legros, Myriam and Bacher, Ulrike and Seipel, Katja and Pabst, Thomas and Radpour, Ramin and Riether, Carsten and Ochsenbein, Adrian F},
title = {CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target},
journal = {Leukemia},
year = {2026},
volume = {40},
number = {6},
pages = {1163--1175},
doi = {10.1038/s41375-026-02899-1}
}
EUVIMED